(Q34744300)

4 August 2017

1 reference

title

Antimicrobial resistance and aging: beginning of the end of the antibiotic era? (English)

1 reference

4 August 2017

main subject

antimicrobial resistance

1 reference

based on heuristic

inferred from title

antibiotic resistance

1 reference

Thomas T Yoshikawa

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Journal of the American Geriatrics Society

4 August 2017

published in

1 reference

4 August 2017

volume

50

1 reference

4 August 2017

issue

7 Suppl

1 reference

4 August 2017

page(s)

S226-9

1 reference

Perspective: aging and infectious diseases: past, present, and future

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Clinical relevance of age-related immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Approach to fever and infection in the nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Diagnosis and treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

VRE, MRSA, PRP, and DRGNB in LTCF: lessons to be learned from this alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Vancomycin-resistant Staphylococcus aureus: infection control considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Preventing the spread of vancomycin-resistant enterococci in a long-term care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.50.7S.2.X

10.1046/J.1532-5415.50.7S.2.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference